PT/INR vs aPTT: What Is the Difference?
Test sonuçlarınızı doktorunuzla birlikte değerlendirin. Bu sayfa bilgilendirme amaçlıdır, tanı koymaz.
💡 Quick Answer
PT/INR and aPTT both measure clotting time but evaluate different parts of the coagulation cascade. PT/INR assesses the extrinsic and common pathways and is the standard for warfarin monitoring. aPTT assesses the intrinsic and common pathways and is the standard for heparin monitoring.
🧪 What Is PT/INR?
PT (prothrombin time) measures how long it takes blood to clot via the extrinsic and common pathways. INR standardizes PT results across different laboratories and reagents. PT/INR is the primary test for monitoring warfarin therapy and evaluating liver synthetic function.
🧪 What Is aPTT?
aPTT (activated partial thromboplastin time) measures clotting time via the intrinsic and common pathways. It is the standard test for monitoring unfractionated heparin therapy and investigating intrinsic pathway factor deficiencies.
📊 Comparison Table
| Criterion | PT/INR | aPTT |
|---|---|---|
| Pathway evaluated | Extrinsic + common pathway (Factors VII, X, V, II, fibrinogen) | Intrinsic + common pathway (Factors XII, XI, IX, VIII, X, V, II, fibrinogen) |
| Primary use | Warfarin monitoring, liver function assessment | Heparin monitoring, bleeding disorder investigation |
| Normal values | PT: ~10–13.5 sec | INR: ~0.8–1.1 (without anticoagulants) | ~25–40 seconds (varies by laboratory) |
| Drug monitored | Warfarin (target INR usually 2.0–3.0) | Unfractionated heparin (target 1.5–2.5× control) |
| Prolonged by | Warfarin, liver disease, vitamin K deficiency, DIC | Heparin, factor deficiencies (VIII, IX, XI, XII), lupus anticoagulant, DIC |
| Key advantage | INR standardization allows comparison across labs | Sensitive to intrinsic pathway factors and heparin effect |
| Key limitation | Does not detect intrinsic pathway deficiencies | Lupus anticoagulant prolongs aPTT without bleeding risk |
🔀 When Is Each One Ordered?
PT/INR is ordered for warfarin monitoring, preoperative screening, and liver function assessment. aPTT is ordered for heparin monitoring, investigating unexplained bleeding, and screening for intrinsic pathway deficiencies. Both are often ordered together for comprehensive coagulation assessment.
🤝 Are They Ordered Together?
Yes, they are frequently ordered together as a coagulation panel. The combination covers both major clotting pathways. If only PT or only aPTT is prolonged, it helps localize the defect to a specific pathway.
🎯 When Is One More Informative?
PT/INR is essential for warfarin management. aPTT is essential for heparin management. For investigating unexplained bleeding, both are needed. PT is also more informative for liver synthetic function assessment.
❓ Frequently Asked Questions
Can both be prolonged at the same time?
Yes. This suggests a defect in the common pathway (Factor X, V, II, or fibrinogen) or a systemic condition like DIC or severe liver disease.
Does a normal PT/INR and aPTT rule out bleeding disorders?
Not entirely. Some conditions like platelet disorders or von Willebrand disease may not affect PT or aPTT.
Why is INR used instead of PT?
INR standardizes PT results across different laboratories and reagents, making warfarin dose adjustments consistent regardless of where the test is performed.
🔗 Related Tests
Content is based on scientific studies indexed in PubMed and current clinical guidelines.